基本信息
浏览量:8
职业迁徙
个人简介
More recently, Dr. Feng’s group discovered a tumor-suppressor role of Shp2/Ptpn11 in liver cancer (Cancer Cell, 2011), in contrast to its leukemogenic effect. The current focus of the lab is on deciphering the dual functions and mechanisms of signaling molecules in hepatocarcinogenesis (Cancer Cell, 2012), with the goal of developing better therapeutic strategies and identifying biomarkers for early diagnosis of liver cancer patients.
Dr. Feng received a career development award from American Diabetes Association. He has served on editorial boards for MCB, JBC, Cell Res and J. Hepatology.
Dr. Feng received a career development award from American Diabetes Association. He has served on editorial boards for MCB, JBC, Cell Res and J. Hepatology.
研究兴趣
论文共 195 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
HEPATOLOGY COMMUNICATIONSno. 4 (2024)
Xinyi Wang, Jiemeng Zhang, Yingluo Liu, Shuo Zhang,Yan Liang,Min Zong,Xiaoxue Lin,Michael Karin,Gensheng Feng
Cancer Researchno. 6_Supplement (2024): 2274-2274
Yingluo Liu,Gen-sheng Feng
Cellular and molecular gastroenterology and hepatologyno. 1 (2024): 171-172
eLife (2023)
Cellular and molecular gastroenterology and hepatologyno. 6 (2023): 1351-1369
HEPATOLOGY (2023): S2004-S2005
引用0浏览0引用
0
0
Journal of Cancer Research and Practiceno. 2 (2023): 45-45
引用0浏览0引用
0
0
Meng Liu,Mengjun Ji,Jianghong Cheng, Yingzhe Li,Yingpu Tian, Hui Zhao,Yang Wang,Sijing Zhu, Leilei Zhang, Xinmei Xu,Gen-Sheng Feng,Xiaohuan Liang,
Nature communicationsno. 1 (2023): 1-14
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn